Back to Search
SARAH YOUNT, PHARMD
PHARMD
Pharmacist
NPI: 1568022861Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
15602(OK)
Research & Publications (20)
A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease.
PMID 19402847·Value Health·2009
8-other
Fertility preservation and adolescent cancer patients: lessons from adult survivors of childhood cancer and their parents.
PMID 18080667·Cancer Treat Res·2007
6-review
Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
PMID 17951232·J Natl Cancer Inst Monogr·2007
6-review
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
PMID 17944147·J Support Oncol·2007
8-other
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
PMID 17922221·Qual Life Res·2007
2-rct
Validation of the functional assessment of cancer therapy--lung symptom index-12 (FLSI-12).
PMID 17485135·Lung Cancer·2007
4-observational
The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.
PMID 17443116·Med Care·2007
8-other
Evaluation of item candidates: the PROMIS qualitative item review.
PMID 17443114·Med Care·2007
8-other
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
PMID 16669463·J Support Oncol·2006
4-observational
Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.
PMID 15868614·J Rheumatol·2005
4-observational
Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI).
PMID 15830143·Breast Cancer Res Treat·2005
4-observational
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.
PMID 15504633·J Clin Epidemiol·2004
8-other
Measurement and management of health-related quality of life in lung cancer.
PMID 16163227·Clin Adv Hematol Oncol·2004
6-review
What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).
PMID 14533442·Cancer Invest·2003
8-other
Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
PMID 12697878·J Clin Oncol·2003
3-trial
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
PMID 14633279·Health Qual Life Outcomes·2003
4-observational
Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancers: the FACT Hepatobiliary Symptom Index.
PMID 12183093·J Pain Symptom Manage·2002
4-observational
Methods and progress in assessing the quality of life effects of supportive care with erythropoietin therapy.
PMID 11953670·Curr Opin Hematol·2002
6-review
Mucositis in head and neck cancer: economic and quality-of-life outcomes.
PMID 11694566·J Natl Cancer Inst Monogr·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 CAMPUS DR
WEATHERFORD, OK 73096 - Phone
- (580) 774-6042
Quick Facts
- NPI
- 1568022861
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile